Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Shanghai Henlius Biotech
Scientific Title
A Randomized, Double-Blind, International Multicenter, Phase III Study to Evaluate the Anti-Tumor Efficacy and Safety of HLX10 or Placebo in Combination With Chemotherapy and Concurrent Radiotherapy in Patients With Limited-Stage Small Cell Lung Cancer